A multicenter prospective trial was performed to investigate the efficacy and the tolerability of halofantrine in nonimmune patients with malaria imported from areas with drug-resistant falciparum parasites (mainly Africa). Forty-five of the 74 subjects were treated with a one-day regimen (3 x 500 mg) of halofantrine, and the other 29 received the same regimen with an additional treatment on day 7. In the second group, a 100% efficacy rate was demonstrated, but in the group receiving the one-day regimen, four recrudescences were observed in patients with falciparum malaria. Only five mild adverse reactions were seen, which disappeared spontaneously after the end of the treatment. We conclude that halofantrine is highly effective in curing malaria in nonimmune subjects. The treatment scheme for such persons should include an additional treatment on day 7 for nonimmune individuals. This drug was well tolerated in our patients, indicating that halofantrine will be useful in the treatment of multidrug-resistant malaria in nonimmune persons.

Download full-text PDF

Source

Publication Analysis

Top Keywords

malaria nonimmune
12
one-day regimen
8
additional treatment
8
treatment day
8
treatment
6
malaria
5
nonimmune
5
efficacy halofantrine
4
halofantrine treatment
4
treatment acute
4

Similar Publications

parasites undergo development and replication within the hepatocytes before infecting the erythrocytes and initiating clinical malaria. Although type-I interferons (IFNs) are known to hinder infection within the liver, the underlying mechanisms remain unclear. Here, we describe two IFN-I-driven hepatocyte antimicrobial programs controlling liver-stage malaria.

View Article and Find Full Text PDF
Article Synopsis
  • Malaria, particularly caused by the Plasmodium falciparum parasite, poses a major public health issue, and osteopontin (OPN) plays a role in regulating the immune response during acute malaria, though its exact effects in humans are not fully understood.
  • Blood samples from various groups, including Swedish adults and Ugandan patients, indicated that OPN levels were significantly higher during acute malaria infection, especially in children, with correlations found between OPN, interferon-γ, and parasite levels.
  • The study concludes that elevated OPN levels in acute malaria relate more closely to a lack of immunity rather than age, highlighting OPN's potential significance in understanding malaria, especially in individuals who are not immune.
View Article and Find Full Text PDF

Malaria, which is caused by infection of red blood cells with Plasmodium parasites, can be fatal in non-immune individuals if left untreated. The recent approval of the pre-erythrocytic vaccines RTS, S/AS01 and R21/Matrix-M has ushered in hope of substantial reductions in mortality rates, especially when combined with other existing interventions. However, the efficacy of these vaccines is partial, and chemotherapy remains central to malaria treatment and control.

View Article and Find Full Text PDF

Introduction: The use of long-lasting insecticide-treated net (LLIN) is one of the most effective malaria prevention strategies, particularly among pregnant women. It has mosquito-killing repellent and physical barrier properties. Pregnant women, children under 5 years of age, and patients with HIV/AIDS, as well as non-immune migrants, mobile populations, and travelers, are the most vulnerable groups to malaria.

View Article and Find Full Text PDF

Malaria is an acute febrile illness. It is a dangerous disease that contributes to millions of hospital visits and hundreds of thousands of deaths, especially in children residing in sub-Saharan Africa. In a non-immune individual, symptoms usually appear 10-15 days after the infective mosquito bite.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!